279 related articles for article (PubMed ID: 38711394)
21. Antiproliferative effect, cell cycle arrest and apoptosis generation of novel synthesized anticancer heterocyclic derivatives based 4H-benzo[h]chromene.
Alblewi FF; Okasha RM; Hritani ZM; Mohamed HM; El-Nassag MAA; Halawa AH; Mora A; Fouda AM; Assiri MA; Al-Dies AM; Afifi TH; El-Agrody AM
Bioorg Chem; 2019 Jun; 87():560-571. PubMed ID: 30928878
[TBL] [Abstract][Full Text] [Related]
22. From indole to pyrrole, furan, thiophene and pyridine: Search for novel small molecule inhibitors of bacterial transcription initiation complex formation.
Thach O; Mielczarek M; Ma C; Kutty SK; Yang X; Black DS; Griffith R; Lewis PJ; Kumar N
Bioorg Med Chem; 2016 Mar; 24(6):1171-82. PubMed ID: 26860928
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, antibacterial, and antiviral evaluation of new heterocycles containing the pyridine moiety.
Salem MS; Sakr SI; El-Senousy WM; Madkour HM
Arch Pharm (Weinheim); 2013 Oct; 346(10):766-73. PubMed ID: 24105721
[TBL] [Abstract][Full Text] [Related]
24. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
Sławiński J; Szafrański K; Vullo D; Supuran CT
Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
[TBL] [Abstract][Full Text] [Related]
25. Ultrasound-assisted bismuth nitrate-induced green synthesis of novel pyrrole derivatives and their biological evaluation as anticancer agents.
Bandyopadhyay D; Mukherjee S; Granados JC; Short JD; Banik BK
Eur J Med Chem; 2012 Apr; 50():209-15. PubMed ID: 22341658
[TBL] [Abstract][Full Text] [Related]
26. Anti-hepatocellular carcinoma activity using human HepG2 cells and hepatotoxicity of 6-substituted methyl 3-aminothieno[3,2-b]pyridine-2-carboxylate derivatives: in vitro evaluation, cell cycle analysis and QSAR studies.
Abreu RM; Ferreira IC; Calhelha RC; Lima RT; Vasconcelos MH; Adega F; Chaves R; Queiroz MJ
Eur J Med Chem; 2011 Dec; 46(12):5800-6. PubMed ID: 22014996
[TBL] [Abstract][Full Text] [Related]
27. Potential 2,4-dimethyl-1H-pyrrole-3-carboxamide bearing benzimidazole template: Design, synthesis, in vitro anticancer and in silico ADME study.
Rasal NK; Sonawane RB; Jagtap SV
Bioorg Chem; 2020 Apr; 97():103660. PubMed ID: 32086056
[TBL] [Abstract][Full Text] [Related]
28. A Comprehensive Review on Journey of Pyrrole Scaffold Against Multiple Therapeutic Targets.
Mir RH; Mir PA; Mohi-Ud-Din R; Sabreen S; Maqbool M; Shah AJ; Shenmar K; Raza SN; Pottoo FH
Anticancer Agents Med Chem; 2022; 22(19):3291-3303. PubMed ID: 35702764
[TBL] [Abstract][Full Text] [Related]
29. Bioactive pyrrole-based compounds with target selectivity.
Li Petri G; Spanò V; Spatola R; Holl R; Raimondi MV; Barraja P; Montalbano A
Eur J Med Chem; 2020 Dec; 208():112783. PubMed ID: 32916311
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of novel alkyl amide functionalized trifluoromethyl substituted pyrazolo[3,4-b]pyridine derivatives as potential anticancer agents.
Chavva K; Pillalamarri S; Banda V; Gautham S; Gaddamedi J; Yedla P; Kumar CG; Banda N
Bioorg Med Chem Lett; 2013 Nov; 23(21):5893-5. PubMed ID: 24060486
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of copper and zinc 2-(pyridin-2-yl)imidazo[1,2-a]pyridine complexes and their potential anticancer activity.
Dam J; Ismail Z; Kurebwa T; Gangat N; Harmse L; Marques HM; Lemmerer A; Bode ML; de Koning CB
Eur J Med Chem; 2017 Jan; 126():353-368. PubMed ID: 27907874
[TBL] [Abstract][Full Text] [Related]
32. Caspase-3 Activators as Anticancer Agents.
Srivastava N; Saxena AK
Curr Protein Pept Sci; 2023; 24(10):783-804. PubMed ID: 36843371
[TBL] [Abstract][Full Text] [Related]
33. Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents.
Azad I; Nasibullah M; Khan T; Hassan F; Akhter Y
J Mol Graph Model; 2018 May; 81():211-228. PubMed ID: 29609141
[TBL] [Abstract][Full Text] [Related]
34. Updates on Receptors Targeted by Heterocyclic Scaffolds: New Horizon in Anticancer Drug Development.
Kharb R
Anticancer Agents Med Chem; 2021; 21(11):1338-1349. PubMed ID: 32560614
[TBL] [Abstract][Full Text] [Related]
35. Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity.
Gibson MZ; Nguyen MA; Zingales SK
Med Chem; 2018; 14(4):333-343. PubMed ID: 29065840
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and cytotoxicity studies of novel pyrazolo[1, 5-a]pyridine derivatives.
Ravi C; Qayum A; Chandra Mohan D; Singh SK; Adimurthy S
Eur J Med Chem; 2017 Jan; 126():277-285. PubMed ID: 27889631
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, Anticancer Screening and Molecular Docking Studies of New Heterocycles with Trimethoxyphenyl Scaffold as Combretastatin Analogues.
Ali KA; Abdel Hafez NA; Elsayed MA; El-Shahawi MM; El-Hallouty SM; Amr AEE
Mini Rev Med Chem; 2018; 18(8):717-727. PubMed ID: 28443521
[TBL] [Abstract][Full Text] [Related]
38. Nitrogen-Containing Heterocycles as Anticancer Agents: An Overview.
Lang DK; Kaur R; Arora R; Saini B; Arora S
Anticancer Agents Med Chem; 2020; 20(18):2150-2168. PubMed ID: 32628593
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of Pyridine-Dicarboxamide-Cyclohexanone Derivatives: Anticancer and α-Glucosidase Inhibitory Activities and In Silico Study.
Al-Majid AM; Islam MS; Atef S; El-Senduny FF; Badria FA; Elshaier YAMM; Ali M; Barakat A; Motiur Rahman AFM
Molecules; 2019 Apr; 24(7):. PubMed ID: 30987350
[TBL] [Abstract][Full Text] [Related]
40. New Approaches for the Synthesis of Fused Thiophene, Pyrazole, Pyran and Pyridine Derivatives with Anti-Proliferative Together with c-Met Kinase and Prostate Cancer Cell Inhibitions.
Mohareb RM; Milad YR; El-Ansary RA
Anticancer Agents Med Chem; 2021; 21(13):1751-1766. PubMed ID: 33176664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
